identification of 8 BALB/c myelomas (out of a total of 277 examined) that have light chains indistinguishable from the marker light chain bands. In contrast, no light chains that cofocused precisely with the marker bands were identified among a total of 133 NZB myelomas (5) .
We have now obtained partial amino acid sequences of 3 of the BALB/c light chains in question, and all 3 have been found to share an identical amino acid sequence over the first 30 residues. This result provides strong support for the notion that at least some of the discrete focusing bands (IF bands) observed in normal serum immunoglobulin light chains represent light chains that belong to the same V-region group (if not subgroup). It also suggests that the genetic polymorphism may be a result of the absence of a single V, gene or of a cluster of closely related V~ genes in Ef2 b strains of mice. The surprisingly high frequency of light chains of the Ef2-related group among BALB/c myelomas suggests that it may represent one of a small number of V~ groups expressed at an elevated level.
Materials and Methods
Mouse Myeloma Ascites Fluids. Samples of BALB/c myeloma ascites fluids selected at random from the BALB/c myeloma collection were generously supplied by Dr. Michael Potter of the National Cancer Institute (Bethesda, Md.). Samples of myeloma aseites fluids of NZB mice were selected only for being good producers and were otherwise a random sample. These samples were generously donated by Dr. Martin Weigert of the Institute for Cancer Research, Philadelphia, Pa.
Production of large amounts of immunoglobulin from the BALB/c tumors TEPC-817, FLOPC-1, and TEPC (CAL-20)-105 was undertaken at the University of Sherbrooke (Sherbrooke, Canada) using pristane-primed BALB/cByJ mice or CAL-20 mice obtained from Dr. Judy Wax at Litton Bionetics, Kensington, Md.
Isolation oflmmunoglobulins and Light Chains. Ascites fluids were delipidated then diluted with an equal volume of phosphate-buffered saline (PBS). A vol of 3.5 M ammonium sulfate, pH 7.3, equal to the diluted volume was then added, and precipitation was allowed to proceed for 1 h at 0°C. The precipitate was redissolved in twice the original fluid volume of PBS, and the precipitation step was repeated. After three precipitations, the immunoglobulin was redissolved, dialyzed against dilute ammonium bicarbonate, and lyophilized. Immunoglobulin was subjected to partial sulfityolysis and heavy and light chains separated by gel filtration on Sephadex G100 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) in the presence of 0.1% sodium dodecyl sulfate as described (13) . Light chains were then desalted on Sephadex G25 in ammonium carbonate and lyophilized. All light chain preparations were rechromatographed a second time on Sephadex G100. An alternative procedure, used for small preparations of light chain, was partial reduction and alkylati0n with iodoacetamide followed by gel filtration on Ultragel ACA 34 in the presence of 3 M guanidine HCI and 0.2 M ammonium bicarbonate (14) .
Sequenator Procedures. A I-M quadrol program was used (15) on a modified Illitron model 9001 sequenator (Illitron, Division of Illinois Tool Works Inc., Chicago, Ill.). Program modifications, such as solvent precipitation steps (16) , were also incorporated. Conversion of thiazolinone amino acid derivatives was done manually, using 25% trifluoroaeetic acid (TFA) at 60°C for 20 rain. After drying of the TFA, the entire residue was dissolved in 0.2 ml of methanol: acetonitrile (50:50) for injection into the high-performance liquid chromatograph (HPLC). Phenylthiohydantoin (PTH) amino acids were identified by HPLC using a Waters solvent programmer and delivery system, dual wavelength detector (254 and 313 nm) (Waters Associates, Inc., Milford, Mass.) and a Dupont 4.6-mm × 25-cm Zorbax CN column (E. I. DuPont de Nemours & Co., Inc., Wilmington, Del.). Conditions ofelution were similar to those described by Johnson et al. (17) . The gradient was from 0 to 55% solvent B (15% acetonitrile in methanol) using curv~ 2 over 20 rain. Solvent A consisted of 0.0167 M sodium acetate buffer (pH 4.7). All solvents were millipore filtered. Solvent A was also sterilized by autoclaving. In addition to HPLC, in certain instances, residues were hydrolyzed and analyzed as free amino acids using a Technicon TSM-1 amino acid analyzer (Technicon Instruments Corp., Tarrytown, N. Y.) (18) .
IF.
Procedures for purification of normal immunoglobulin, light chain isolation, and IF of normal light chains have been described (3, 5) . For the analysis of myeloma ascites fluids, 1/~1 of fluid was subjected to complete reduction and alkylation with [*4C]iodoacetamide (50 mCi/ mmol; Amersham Corp., Arlington Heights, Ill.), as described. The reduced and alkylated material was directly loaded on the urea formate gel for chain separation. Because no purification of the myeloma immunoglobulin was carried out, the myeloma light chain patterns were often contaminated by extraneous minor bands. In all cases the myeloma light chain bands were unequivocally identifiable as major unique bands. 
Results

Differences Expressed in
N-Terminal Sequences of Ef2-related Light Chains.
Three of the BALB/c myeloma light chains corresponding to the Ef2 marker bands were each sequenced at least twice over the N-terminal 40 residues. Unequivocal sequences were obtained for each of the proteins for the first 30 positions using a combination of HPLC and back hydrolysis procedures. Sequence data obtained for the light chain TEPC-817 is illustrated in Fig. 3 . The sequences of the three proteins were indistinguishable from each other and were identical to that of the light chain of MOPC-460, a wellcharacterized dinitrophenyl (DNP)-binding myeloma protein (19) . According to the classification of Potter (20) , these sequences belong to the V~I group. A summary of sequences of light chains closely related to V, 1 is given in Table I .
Closely Related Light Chains Are Present in NZB Mice. Examination of the available
N-terminal sequence data for BALB/c and NZB kappa chains (21) indicated that two light chains with a sequence identical to that of the Ef2 group in the first 23 positions have also been found in NZB myelomas (Table I) . This was somewhat surprising because it was expected that the group (in this case, V~I) representing the polymorphic bands would be reduced considerably, if not absent, in NZB, an IgKEf2 b strain. The two NZB light chains in question--namely, PC2205 and PC2567--were clearly distinct from the El2 group on IF however, which indicated that they must differ structurally from the BALB/c proteins beyond position 23 in the variable region ( Fig. 1 g and h) . It is relevant to note in this context that members of the V~21 group all share an identical sequence in the region of 1-23, but at least six subgroups (V~21A, -B, -C, -D, -E, and -F) are evident when the entire V-region sequence is considered (10) . IF analysis also divides the V~21 group into at least six distinguishable subgroups, more in line with the results of total sequence analysis. Table I. M O P C -4 6 0 light c h a i n showed that it was clearly distinct however, because it focused ~3 c h a r g e U a n o d a l to the Ef2 light chains (Fig. 1 a) . W h e t h e r or not M O P C -4 6 0 light c h a i n m a y be considered to be a somatic m u t a n t o f the E f 2 -r e l a t e d g r o u p is a n interesting q u e s t i o n a n d one that could better be a n s w e r e d w h e n the c o m p l e t e a m i n o acid sequences o f these light chains are available. 
Relationship to MOPC-460 Light
Discussion
In these studies, we believe we have identified one of the important V, groups involved in the Ef2 polymorphism previously described (5) . Sequencing of the first three of the eight BALB/c myelomas found to possess light chains corresponding to the Ef2 marker bands (63 and 54) revealed an identical sequence over the first 30 Recoveries of PTH amino acids in the automated degradation of the light-chain TEPCresidues. The probability of selecting three proteins having sequence identity in the first 30 positions by chance is extremely low, so that the result, in itself, adds credibility to interpretations of light chain IF data. It seems likely from this result that the majority of the remaining five myelomas identified will also possess the same Nterminal sequence. Complete sequencing of these light chains is under way to determine whether they constitute a single subgroup or whether they represent several closely related subgroups. The frequency of occurrence of the Ef2-related light chains (8 out of a total of 277 myelomas examined) suggests that the group must be one of a relatively small number of groups. According to the Poisson formula, if all samples fell into one of 100 equal groups, the expected proportion of groups represented 8 or more times would be 0.0066. If there were 50 groups, the expected proportion represented 8 or more times would be 0.178, a more reasonable probability. This calculation would therefore suggest that the number of groups of light chains similar to the El2 group would be closer to 50 than to 100. Whether or not the sequences represented in the myelomas are a valid sampling of the total repertoire is of crucial importance in considering extrapolation of these calculations to the total number of light-chain groups. This point has been raised by Loh et al. (21) in their analysis of the sequences of randomly selected BALB/c and NZB kappa chains. Our results indicate that the proportion of Ef2-related light chains in normal serum immunoglobulin and artificially reconstituted mixtures of myeloma proteins is similar, as judged by the relative intensities of the bands on autoradiograms of IF gels.
In considering the implications of the present results for our interpretations of the genetically controlled light-chain polymorphism, the central assumption we must make is that the V, group defined by the cofocusing myelomas is, in fact, the same V~ group that we observe in normal serum light chains (identifiedas bands 63 and 54). We feel this assumption is valid for the following reasons: First, the selection of three light chains identical over the first 30 positions simply by the criterion of IF dramatically demonstrates the validity of the method as a means of identifying sequence-related light chains. There is no reason to doubt that the same degree of selectivity is also obtained when the method is applied to the normal light-chain pool and, therefore, that light chains in the normal pool showing close sequence relationships will focus together as a group or band. Secondly, the finding that three closely related light chains cofocus precisely with the normal light-chain bands 54 and 63 also indicates that a bona fide V~ sequence group corresponding to these bands does, in fact, exist among BALB/c myeloma immunoglobulins. It follows that if such light chains exist in normal serum immunoglobulin they will also eofocus with the marker bands 54 and 63.
The fact that discrete groups of light chains are controlled by the IgK-Ef2 locus is more readily explained by proposing that the polymorphism involves structural V~ genes rather than regulatory loci. Regulatory loci such as that described for the hi light-chain subgroup do, nevertheless, exist (22) , and one could suppose that similar loci might control kappa subgroups as well. This would necessarily be more complicated for kappa chains because there may be on the order of 300 V~ subgroups (23) , which would imply the existence of multiple regulatory loci. Other Ly-2,3-1inked V~ loci such as lgK-Efl (24) , IgK-Pc (25) , and IgK-Trp (26) , each of which appears to control structurally related subsets of kappa chains, could also be supposed to represent V~ regulatory loci. One weakness of the argument for regulatory loci is that it implies some functional significance for each control group of light chains. Because light chains of each V~ subgroup are believed to associate with a wide variety (if not all possible) heavy chain variable region partners to give different functional combinations, the existence of a specific function for individual V~ genes is unlikely. If it is assumed that the polymorphism is a result of differences in content of V~ genes or in sequences adjacent to V, genes directly affecting their expression; the present results The finding that one of the major groups of light chain controlled by IgK-Ef2 is closely related to the MOPC-460 light chain has implications in terms of the anti-DNP antibody response. Because it is known that MOPC-460 has a high affinity for DNP (31) it will be interesting to examine light chains produced in the DNP response in strains of mice differing with respect to lgK-Ef2. We are currently engaged in these studies. It is of great interest to note that others have found that Ef2 b strains such as C58 are unable to produce anti-DNP antibodies carrying the MOPC-460 idiotype (32) . It seems likely from this result that Ef2-controlled light chains may well be involved in the anti-DNP immune response and, in particular, that they may be the subgroup required for expression of the MOPC-460 idiotype.
It is clear that resolution of the question of whether the light-chain polymorphism involves regulatory or structural genes will require direct examination of the structural genes. The identification of a major structurally related set of light chains controlled by the lgK-Ef2 locus will greatly aid in this analysis. It should be noted though that sequences closely related to the polymorphic group are also found in IgK-Ef2 b strains (e.g., NZB), and this could complicate attempts to directly demonstrate the absence of given V, structural genes at the DNA level.
Summary
We previously demonstrated that loci closely linked to the Ly-3 locus control the expression of distinct sets of light chains in normal mouse serum immunoglobulin. The frequency of occurrence of the group within the BALB/c myeloma collection (8 out of 277) suggests that the number of such groups may be closer to 50 than to 100. The finding supports an interpretation of the genetic polymorphism as being in part a result of the absence of genes related to V~I in IgK-Ef2 b strains of mice.
